Antipsychotics increase mortality in elderly patients with dementia (no date). Available at: http://www.npc.nhs.uk/merec/cns/dementia/merec_extra_no39.php.
Aricept Tablets - Summary of Product Characteristics (SPC) - (eMC) (no date). Available at: http://www.medicines.org.uk/emc/medicine/577/SPC/Aricept.
Bhasin, M. et al. (2007) ‘Cholinesterase inhibitors in dementia with Lewy bodies—a comparative analysis’, International Journal of Geriatric Psychiatry, 22(9), pp. 890–895. Available at: https://doi.org/10.1002/gps.1759.
British National Formulary (no date). Available at: http://www.bnf.org/bnf/index.htm.
Centre for Medicines Optimisation - MTRAC | Independent Medicines Review | Midlands Therapeutics Review & Advisory Committee | Centre for Medicines Optimisation | Keele University (no date). Available at: http://centreformedicinesoptimisation.co.uk/mtrac/.
Chronic obstructive pulmonary disease (no date). Available at: http://cks.nice.org.uk/chronic-obstructive-pulmonary-disease.
Clinical guidelines, CG42 - Issued: November 2006 (no date). Available at: http://guidance.nice.org.uk/CG42.
‘Coeliac disease: recognition, assessment and management | Guidance and guidelines | NICE’ (no date). Available at: https://www.nice.org.uk/guidance/ng20.
Commissioners and healthcare professionals - Training videos (no date). Available at: http://healthcheck.nhs.uk/commissioners_and_providers/training/training_videos1/.
Complete Guide to Behavioural and Psychological symptoms of Dementia (no date). Available at: http://www.ipa-online.org/.
CPPE - Centre for Pharmacy Postgraduate Education (no date). Available at: https://www.cppe.ac.uk/.
DH Living well with dementia: a National Dementia Strategy (no date). Available at: https://www.gov.uk/government/organisations/department-of-health.
Ebixa 5mg/pump actuation oral solution, 20mg and 10 mg Tablets and Treatment Initiation Pack - Summary of Product Characteristics (SPC) - (eMC) (no date). Available at: http://www.medicines.org.uk/EMC/medicine/10175/SPC/rEbxia+5mg+pump+oral+solution%252c+20mg+and+10+mg+tablets+and+Treatment+Initiation+Pack/.
Electronic Medicines Compendium (eMC) (no date a). Available at: http://www.medicines.org.uk/emc/.
Electronic Medicines Compendium (eMC) (no date b). Available at: http://www.medicines.org.uk/emc/.
Electronic Medicines Compendium (eMC) (no date c). Available at: https://www.medicines.org.uk/emc/.
Evidence Search - Search Engine for Evidence in Health and Social Care (no date a). Available at: https://www.evidence.nhs.uk/.
Evidence Search - Search Engine for Evidence in Health and Social Care (no date b). Available at: https://www.evidence.nhs.uk/.
Evidence Search - Search Engine for Evidence in Health and Social Care (no date c). Available at: https://www.evidence.nhs.uk/.
Exelon - Summary of Product Characteristics (SPC) - (eMC) (no date). Available at: https://www.medicines.org.uk/emc/search?q=Exelon+.
GOV.UK (no date). Available at: https://www.gov.uk/government/organisations/department-of-health.
Greene, R.J. and Harris, N.D. (2008) Pathology and therapeutics for pharmacists: a basis for clinical pharmacy practice. 3rd ed. London: Pharmaceutical Press.
Heart failure - chronic (no date). Available at: http://cks.nice.org.uk/heart-failure-chronic.
Hubley, J., Copeman, J. and Woodall, J. (2013) Practical health promotion. 2nd ed. Cambridge: Polity Press.
Kavirajan, H. and Schneider, L.S. (2007) ‘Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials’, The Lancet Neurology, 6(9), pp. 782–792. Available at: https://doi.org/10.1016/S1474-4422(07)70195-3.
Kumar, P.J. and Clark, M.L. (2012) Kumar & Clark’s clinical medicine. 8th ed. Edinburgh: Saunders Elsevier. Available at: https://www.dawsonera.com/abstract/9780702053047.
Laverack, G. (2007) Health promotion practice: building empowered communities. Maidenhead: Open University Press. Available at: https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=nlebk&AN=234222&site=ehost-live&scope=site&custid=s8454451.
Macdowall, W., Bonell, C. and Davies, M. (2006) Health promotion practice. Maidenhead: Open University Press.
Maher, A.R. et al. (2011) ‘Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults’, JAMA, 306(12). Available at: https://doi.org/10.1001/jama.2011.1360.
Maher, A.R. (2011) ‘Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in AdultsA Systematic Review and Meta-analysis’, JAMA: The Journal of the American Medical Association, 306(12). Available at: https://doi.org/10.1001/jama.2011.1360.
Map of Medicine | Home (no date). Available at: http://www.mapofmedicine.com/.
Martinón-Torres, G., Fioravanti, M. and Grimley Evans, J. (2004) ‘Trazodone for agitation in dementia’, Cochrane Database of Systematic Reviews [Preprint]. Available at: https://doi.org/10.1002/14651858.CD004990.
Medicines Information - Evidence Search - Search Engine for Evidence in Health and Social Care (no date). Available at: https://www.evidence.nhs.uk/.
‘Medicines Use Review and Prescription Intervention service’ (no date). Available at: http://psnc.org.uk/wp-content/uploads/2013/06/MUR-service-spec-Aug-2013-changes_FINAL.pdf.
Miller, W.R. and Rollnick, S. (2013) Motivational interviewing: helping people change. 3rd ed. New York: Guilford Press.
National Institute for Health and Care Excellence (no date). Available at: http://www.nice.org.uk/.
NHS Health Check - NHS Choices (no date). Available at: http://www.nhs.uk/Conditions/nhs-health-check/Pages/NHS-Health-Check.aspx.
NICE Clinical Knowledge Summaries (CKS) (no date). Available at: http://cks.nice.org.uk/.
NPC | National Prescribing Centre (no date a). Available at: https://www.guidelinesinpractice.co.uk.
NPC | National Prescribing Centre (no date b). Available at: https://www.guidelinesinpractice.co.uk.
Optimising treatment and care for behavioural and psychological symptoms of dementia: A best practice guide (no date). Available at: https://www.alzheimers.org.uk/bpsdguide.
Pierre N. Tariot, M.D.; Rosemary Erb, R.N., B.S.N.; Carol Ann Podgorski, Ph.D.; Christopher Cox, Ph.D.; Shirish Patel, M.D.; Laura Jakimovich, M.S., R.N.; Carrie Irvine, B.A. (1998) ‘Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia’, PsychiatryOnline | American Journal of Psychiatry | Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia, 155(1), pp. 54–61. Available at: https://doi.org/10.1176/ajp.155.1.54.
Prochaska, J.O., Norcross, J.C. and DiClemente, C.C. (1994) Changing for good. New York: William Morrow.
Reminyl Tablets - Summary of Product Characteristics (SPC) - (eMC) (no date).
Risperdal Tablets, Liquid & Quicklet - Summary of Product Characteristics (SPC) - (eMC) (no date). Available at: http://www.medicines.org.uk/emc/document.aspx?documentid=12818&docType=SPC.
Rollnick, S., Mason, P. and Butler, C. (1999) Health behavior change: a guide for practitioners. Edinburgh: Churchill Livingstone.
Rollnick, S., Miller, W.R. and Butler, C. (2008) Motivational interviewing in health care: helping patients change behavior. New York: Guilford Press.
Royal Pharmaceutical Society (RPS) (no date). Available at: http://www.rpharms.com/home/home.asp.
Scottish Intercollegiate Guidelines Network (SIGN) (no date). Available at: http://www.sign.ac.uk/.
‘Service specification - New Medicine Service (NMS)’ (no date). Available at: http://psnc.org.uk/wp-content/uploads/2013/06/NMS-service-spec-Aug-2013-changes_FINAL.pdf.
Sube Banerjee (12AD) ‘The use of antipsychotic medication for people with dementia: Time for action. A report for the Minister of State for Care Services’. Available at: http://psychrights.org/research/digest/nlps/BanerjeeReportOnGeriatricNeurolepticUse.pdf.
TA217 Alzheimer’s disease - donepezil, galantamine, rivastigmine and memantine: guidance (MS Word format) (no date). Available at: http://guidance.nice.org.uk/TA217/Guidance/doc/English.
Treatment protocol by NHS Medway: Treatment of Behaviour That Challenges (no date). Available at: http://www.kmpt.nhs.uk/policies.
Waldemar, G. et al. (2008) ‘Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer’s disease’, International Journal of Geriatric Psychiatry, 23(9), pp. 979–981. Available at: https://doi.org/10.1002/gps.1979.
Walker, R. and Whittlesea, C. (2012) Clinical pharmacy and therapeutics. 5th ed. Edinburgh: Churchill Livingstone. Available at: https://www.vlebooks.com/Product/Index/173020?page=0&startBookmarkId=-1.
Warner, J. and Smith, T. (no date) ‘The rise and fall of antipsychotic prescribing in dementia. Where do we go from here?’, The rise and fall of antipsychotic prescribing in dementia, 14(2), pp. 24–27.